Patents Assigned to ATEN PORUS LIFESCIENCES PVT. LTD.
  • Publication number: 20230002387
    Abstract: Compounds, pharmaceutical compositions, and methods are provided herein that may be used to treat cancer, infectious disease, and other conditions associated with ectonucleotide pyrophosphatase pyrophosphatase-phosphodiesterase (ENPP1) dysfunction.
    Type: Application
    Filed: September 15, 2020
    Publication date: January 5, 2023
    Applicants: ATEN PORUS LIFESCIENCES PVT. LTD., AVAMMUNE THERAPEUTICS INC
    Inventors: Aditya KULKARNI, Sandeep GOYAL, Princy KHURANA, Ketul PATEL, Rajath CYRIAC, Bala ANOOP SIRISH KATARU, Mukesh GANGAR, Apurba MUKHERJEE